Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative (Q33900845)

29 July 2017

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative (English)

1 reference

29 July 2017

4

Allison W Kurian

1 reference

29 July 2017

Julia R Trosman

1

1 reference

29 July 2017

Christine B Weldon

2

1 reference

29 July 2017

Michael P Douglas

3

1 reference

29 July 2017

R Kate Kelley

5

1 reference

29 July 2017

Patricia A Deverka

6

1 reference

29 July 2017

Kathryn A Phillips

7

1 reference

29 July 2017

10 February 2017

1 reference

Journal of the National Comprehensive Cancer Network

29 July 2017

1 reference

29 July 2017

15

1 reference

29 July 2017

2

1 reference

29 July 2017

219-228

1 reference

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Availability and payer coverage of BRCA1/2 tests and gene panels.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Gene-panel sequencing and the prediction of breast-cancer risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

The FDA and genomic tests--getting regulation right

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Obama's Precision Medicine Initiative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

A new initiative on precision medicine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Overcoming the reimbursement barriers for clinical sequencing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Gene panel testing for inherited cancer risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Cancer genomics and inherited risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

UnitedHealthcare experience illustrates how payers can enable patient engagement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Barriers to the use of personalized medicine in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Capacity building for assessing new technologies: approaches to examining personalized medicine in practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Health technology assessment and private payers's coverage of personalized medicine.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Real world experience with cancer genetic counseling via telephone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Pharmacogenomics, evidence, and the role of payers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Multigene Panel Testing in Oncology Practice: How Should We Respond?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5508568

NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer

29 October 2018

1 reference

12 December 2020

Insurance companies are slow to cover next-generation sequencing

1 reference

12 December 2020

Multigene panel testing: planning the next generation of research studies in clinical cancer genetics

1 reference

12 December 2020

Health Insurers Struggle to Manage Number, Cost of Genetic Tests

1 reference

12 December 2020

Cutting the Gordian helix--regulating genomic testing in the era of precision medicine

1 reference

12 December 2020

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity

1 reference

12 December 2020

Usefulness of Multigene Testing: Catching the Train That's Left the Station

1 reference

12 December 2020

Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers

1 reference

12 December 2020

Evolution of genetic testing for inherited susceptibility to breast cancer

1 reference

12 December 2020

The FDA and genetic testing

1 reference

12 December 2020

Identifiers

DOI

10.6004/JNCCN.2017.0022

1 reference

29 July 2017

1 reference

29 July 2017

1 reference